Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 972-978

  Hartmann, Joachim ^a   Kiewert, Cornelia ^a   Duysen, Ellen G ^b   Lockridge, Oksana ^b   Klein, Jochen ^a,c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Hemicholinium 3; High affinity choline uptake; Microdialysis; Scopolamine

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINE UPTAKE; ENZYME DEFICIENCY; EX VIVO STUDY; FEMALE; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; CHOLINE; CHOLINERGIC ANTAGONISTS; DOWN-REGULATION; EXTRACELLULAR FLUID; FEMALE; HEMICHOLINIUM 3; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; NEUROTRANSMITTER UPTAKE INHIBITORS; PRESYNAPTIC TERMINALS; SCOPOLAMINE; SEIZURES; SODIUM CHANNEL BLOCKERS; SYNAPTIC TRANSMISSION;

ANIMALIA; MUS;

EID: 40949154762     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.10.008     Document Type: Article

References (37)

1. Amenta F., Tayebati S.K., Vitali D., and Di Tullio M.A. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission. Mech. Aging Dev. 127 (2006) 173-179
2. Bernard V., Brana C., Liste I., Lockridge O., and Bloch B. Dramatic depletion of cell surface m2 muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice. Mol. Cell. Neurosci. 23 (2003) 121-133
3. Birks R.I., and Macintosh F.C. Acetylcholine metabolism at nerve-endings. Br. Med. Bull. 13 (1957) 157-161
4. Blusztajn J.K., and Wurtman R.J. Choline and cholinergic neurons. Science 221 (1983) 614-620
5. Brandon E.P., Mellott T., Pizzo D.P., Coufal N., D'Amour K.A., Gobeske K., Lortie M., Lopez-Corviella I., Berse B., Thal L.J., Gage F.H., and Blusztajn J.K. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J. Neurosci. 24 (2004) 5459-5466
6. Bushnell P.J., Padilla S.S., Ward T., Pope C.N., and Olszyk V.B. Behavioral and neurochemical changes in rats dosed repeatedly with diisofluorophosphate. J. Pharmacol. Exp. Ther. 256 (1991) 741-750
7. Consolo S., Wu C.F., Fiorentini F., Ladinsky H., and Vezzani A. Determination of endogenous acetylcholine release in freely moving rats by transstriatal dialysis coupled to a radioenzymatic assay: effect of drugs. J. Neurochem. 48 (1987) 1459-1465
8. Court J.A., and Perry E.K. Dementia: the neurochemical basis of putative transmitter orientated therapy. Pharmacol. Ther. 52 (1991) 423-443
9. Dutar P., Bassant M.-H., Senut M.-C., and Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev. 75 (1997) 393-427
10. Duysen E.G., Stribley J.A., Fry D.L., Hinrichs S.H., and Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res. Dev. Brain Res. 137 (2002) 43-54
11. Erb C., Troost J., Kopf S., Schmitt U., Löffelholz K., Soreq H., and Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77 (2001) 638-646
12. Ferguson S.M., Savchenko V., Apparsundaram S., Zwick M., Wright J., Heilman C.J., Yi H., Levey A.I., and Blakely R.D. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J. Neurosci. 23 (2003) 9697-9709
13. Ferguson S.M., and Blakely R.D. The choline transporter resurfaces: new roles for synaptic vesicles. Mol. Interventions 4 (2004) 22-37
14. Giacobini E. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res. 50 (2004) 433-440
15. Giovannini M.G., Scali C., Bartolini L., Schmidt B., and Pepeu G. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats. Eur. J. Pharmacol. 354 (1998) 17-24
16. Hartmann J., Kiewert C., Duysen E.G., Lockridge O., Greig N.H., and Klein J. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity. J. Neurochem. 100 (2007) 1421-1429
17. Holden J.T., Rossier J., Beaujouan J.C., Guyenet P., and Glowinski J. Inhibition of high-affinity choline transport in rat striatal synaptosomes by alkyl bisquarternary ammonium compounds. Mol. Pharmacol. 11 (1975) 19-27
18. Ikarashi Y., Takahashi A., Ishimaru H., Arai T., and Maruyama Y. Relations between the extracellular concentrations of choline and acetylcholine in rat striatum. J. Neurochem. 69 (1994) 1246-1251
19. Jope R.S. High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res. Rev. 1 (1979) 313-344
20. Klein J. Functions and pathophysiological roles of phospholipase D in the brain. J. Neurochem. 94 (2005) 1473-1487
21. Klein J., Köppen A., and Löffelholz K. Regulation of free choline in rat brain: dietary and pharmacological manipulations. Neurochem. Int. 32 (1998) 479-485
22. Köppen A., Klein J., Erb C., and Löffelholz K. Acetylcholine release and choline availability in rat hippocampus: effects of exogenous choline and nicotinamide. J. Pharmacol. Exp. Ther. 282 (1997) 1139-1145
23. Kuhar M.J., and Murrin L.C. Sodium-dependent, high affinity choline uptake. J. Neurochem. 30 (1978) 15-21
24. Liu J.K., and Kato T. Effect of physostigmine on relative acetylcholine output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex. Neurochem. Int. 24 (1994) 589-596
25. Löffelholz K., and Klein J. Precursors: choline and glucose. In: Giacobini E., and Pepeu G. (Eds). The Brain Cholinergic System in Health and Disease (2006), Informa Healthcare, Abingdon, UK 75-83
26. Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., and Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
27. Parikh V., and Sarter M. Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. J. Neurochem. 97 (2006) 488-503
28. Pope C.N., Chakraborti T.K., Chapman M.L., and Farrar J.D. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol. Biochem. Behav. 42 (1992) 251-256
29. Ribeiro F.M., Black S.A., Prado V.F., Rylett R.J., Ferguson S.S., and Prado M.A. The "ins" and "outs" of the high-affinity choline transporter CHT1. J. Neurochem. 97 (2006) 1-12
30. Testylier G., and Dykes R.W. Acetylcholine release from frontal cortex in the waking rat measured by microdialysis without acetylcholinesterase inhibitors: effects of diisofluorophosphate. Brain Res. 740 (1996) 307-315
31. Toide K., and Arima T. Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis. Eur. J. Pharmacol. 173 (1989) 133-141
32. Tucek S. Problems in the organization and control of acetylcholine synthesis in brain neurons. Prog. Biophys. Mol. Biol. 44 (1984) 1-46
33. Tzavara E.T., Bymaster F.P., Felder C.C., Made W., Gomeza J., Wess J., MacKinzie D.L., and Nomikos G.G. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol. Psychiatry 8 (2003) 673-679
34. Volpicelli-Daley L.A., Hrabovska A., Duysen E.G., Ferguson S.M., Blakely R.D., Lockridge O., and Levey A.I. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol. Pharmacol. 64 (2003) 1309-1316
35. Wecker L. Choline utilization by central cholinergic neurons. In: Wurtman R.J., and Wurtmann J.J. (Eds). Nutrition and the Brain vol. 8 (1990), Raven Press, New York 139-145
36. Wurtman R.J., Blusztajn J.K., Growdon J.H., and Ulus I.H. Cholinesterase inhibitors increase the brain's need for free choline. In: Giacobini E., and Becker R. (Eds). Current Research in Alzheimer Therapy (1988), Taylor and Francis, London 95-100
37. Xie W., Stribley J.A., Chatonnet A., Wilder P.J., Rizzino A., McComb R.D., Taylor P., Hinrichs S.H., and Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293 (2000) 896-902